Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...

WALTHAM, Mass., August 19, 2024--Global Partners LP (NYSE: GLP) (the "Partnership") today announced that its 2023 Schedule K-3 reflecting items of international tax relevance is available online.

Jeffrey Flier is the former dean of Harvard Medical School. One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class of drugs.

Novo Nordisk's GLP-1 drugs like Ozempic and Wegovy are smash hits. However, another biotech is working on a few programs that could be far better. It has plenty of money, good preliminary results ...

The popularity of medications including Ozempic and Wegovy has businesses scrambling to adapt to their thinner, less-hungry ...

To the Editor: The distribution framework for glucagon-like peptide-1 (GLP-1) receptor agonists proposed by Emanuel et al. in their Perspective article (May 30 issue) 1 considers potential years ...

Kourtney Kardashian just launched an herbal supplement called GLP-1 Daily. GLP-1 drugs like Ozempic and Wegovy are FDA-approved for diabetes and weight-loss. Wellness brands are scrambling to ...

GLP-1 RAs are associated with improved kidney and cardiovascular outcomes beyond their intended hypoglycemic effects, but it is unknown how those outcomes compare with those of tirzepatide ...

(Bloomberg) -- Ares Management Corp. is in advanced talks on an acquisition of GLP Capital Partners Ltd.’s operations outside of China, according to people familiar with the matter, in what ...